Frameshift Genomics has been accepted into the NIH I-Corps accelerator, which is an 8 week accelerator, providing SBIR/STTR awardees with access to a team of bio-tech entrepreneurial experts with proven track records. The I-Corps program has been a huge success for the NSF and NIH and has helped many startups navigate the difficultes of commercializing an academicaly developed technology.

To flesh out the 3 person I-Corps team, Al and Chase will be joined by David Hadley from the University of Utah's Technology & Venture Commercialization office. David brings decades of experience in pharma, genomics, and commercializing academic technology.